Tautomeric Effect of Histidine on the Monomeric Structure of Amyloid β-Peptide(1-42)

被引:34
|
作者
Shi, Hu [1 ]
Lee, Jin Yong [1 ]
机构
[1] Sungkyunkwan Univ, Dept Chem, Suwon 440746, South Korea
来源
ACS CHEMICAL NEUROSCIENCE | 2017年 / 8卷 / 03期
基金
新加坡国家研究基金会;
关键词
Tautomeric effect; amyloid(1-42) peptide; histidine tautomer; sheet structure; protein misfolding; aggregation; MOLECULAR-DYNAMICS SIMULATIONS; ALZHEIMERS-DISEASE; BETA-PEPTIDE; PRECURSOR PROTEIN; GAMMA-SECRETASE; COMBINED MD/NMR; FIBRILS; PH; AGGREGATION; MECHANISM;
D O I
10.1021/acschemneuro.6b00375
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tautomeric state of histidine is one of the factors that influence the structural and aggregation properties of amyloid beta (A beta)-peptide in neutral state. It is worth it to uncover the monomeric properties of A beta(1-42) peptide in comparison with A beta(1-40) peptide. Our replica-exchange molecular dynamics simulations results show that the sheet content of each tautomeric isomer in A beta(1-42) monomer is slightly higher than that in A beta(1-40) monomer except His6(delta)-His13(delta)-His14(delta) (delta delta delta) isomer, implying higher aggregation tendency in A beta(1-42), which is in agreement with previous experimental and theoretical studies. Further analysis indicates that (epsilon epsilon epsilon), (epsilon delta epsilon), (epsilon delta delta), and (delta delta epsilon) isomers prefer sheet conformation although they are in nondominating states. Particularly, it is confirmed that antiparallel beta-sheets of (epsilon delta delta) were formed at K16-E22 (22.0-43.9%), N27-A30 except G29 (21.9-40.2%), and M35-141 except G37 (24.1-43.4%). Furthermore, (eSO) may be the easiest one to overcome structural transformation due to nonobstructing interactions between K16 and/or L17 and histidine residues. The current study will help to understand the tautomeric effect of A beta(1-42) peptide to overcome Alzheimer's disease.
引用
收藏
页码:669 / 675
页数:7
相关论文
共 50 条
  • [31] On methionine and Alzheimer's amyloid β-peptide (1-42)-induced oxidative stress
    Butterfield, DA
    Varadarajan, S
    Aksenova, M
    Link, C
    Yatin, SM
    NEUROBIOLOGY OF AGING, 1999, 20 (03) : 339 - 342
  • [32] IDENTIFICATION AND MAPPING OF LINEAR ANTIGENIC DETERMINANTS OF HUMAN AMYLOID β(1-42) PEPTIDE
    Subramanian, Sarada
    D'Souza, Regina
    Shree, A. N. Divya
    JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY, 2012, 33 (01): : 26 - 34
  • [33] In vitro fibrillogenesis of the amyloid β1-42 peptide:: cholesterol potentiation and aspirin inhibition
    Harris, JR
    MICRON, 2002, 33 (7-8) : 609 - 626
  • [35] Aggregation of Alzheimer Amyloid β Peptide (1-42) on the Multivalent Sulfonated Sugar Interface
    Fukuda, Tomohiro
    Matsumoto, Erino
    Onogi, Shunsuke
    Miura, Yoshiko
    BIOCONJUGATE CHEMISTRY, 2010, 21 (06) : 1079 - 1086
  • [36] Cu2+ inhibits the aggregation of amyloid β-peptide(1-42) in vitro
    Zou, J
    Kajita, K
    Sugimoto, N
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2001, 40 (12) : 2274 - +
  • [37] NAP and D-SAL: neuroprotection against the β amyloid peptide (1-42)
    Gozes, Illana
    Divinski, Inna
    Piltzer, Inbar
    BMC NEUROSCIENCE, 2008, 9 (Suppl 3)
  • [38] The effect of intrahippocampal beta amyloid (1-42) peptide injection on oxidant and antioxidant status in rat brain
    Cetin, Ferihan
    Dincer, Sibel
    BIOGERONTOLOGY: MECHANISMS AND INTERVENTIONS, 2007, 1100 : 510 - 517
  • [39] Molecular Insights into Cu/Zn Metal Response to the Amyloid β-Peptide (1-42)
    Sunda, Anurag Prakash
    Sharma, Anuj Kumar
    ACS PHYSICAL CHEMISTRY AU, 2023, 4 (01): : 57 - 66
  • [40] Controlling Amyloid-β Peptide(1-42) Oligomerization and Toxicity by Fluorinated Nanoparticles
    Saraiva, Ana M.
    Cardoso, Isabel
    Carmo Pereira, M.
    Coelho, Manuel A. N.
    Joao Saraiva, Maria
    Moehwald, Helmuth
    Brezesinski, Gerald
    CHEMBIOCHEM, 2010, 11 (13) : 1905 - 1913